RxDoctor Payments Data

Jennifer Bourke

Nurse Practitioner · Duarte, CANPI 1952012601

Payments from drug & device makers

$705in general payments, 2019–2025

Across 29 payments — averaging $24.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$139
  • Merck$106
  • Daiichi Sankyo Inc.$80
  • Sobi, Inc$57
  • Melinta Therapeutics, LLC$54
  • Takeda Pharmaceuticals U.S.A., Inc.$50
  • plus $219 from 9 others

What the payments were for

  • Food & beverage$705100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$705 in reported general payments places this provider in the 75th percentile of 6,779 nurse practitioner providers in California.

See all nurse practitioner providers in California

Medicare billing

Part B allowed, 2024
$1,911
Medicare patients
20
Services billed
21

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Acyclovir14$162

Paid to pharmacies, not to this prescriber.

Other nurse practitioner in Duarte

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →